ClinicalTrials.gg
Active, not recruitingNCT03702322Updated Oct 10, 2025

Improving Voice Production for Adults With Age-related Dysphonia

An interventional study of Voice therapy: respiratory and Voice therapy: glottal closure in Presbylarynx and Age-Related Dysphonia, sponsored by University of Arizona. Active, not recruiting at 2 sites in United States. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-10-10.

Sponsored by University of Arizona · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
220
Allocation
Not applicable
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 71 studies in Dysphonia with a site in United States — 20 open to participants now, 21 under way, 1 of them phase 3. Dysphonia · United States.

Planned enrollment
3rd of 53
220 · median 32
Started
2019
with 1 other
No phase
31 of 71
12 open now
Primary completion
2026-12
later than 1 of 20 live
Registered
32nd of 71
by date

Among the 71 studies in Dysphonia with a site in United States, this one is the 3rd largest by planned enrollment of the 53 interventional ones that give a count, is one of 2 that started in 2019, is one of 31 with no phase, reaches primary completion later than 1 of the 20 other live ones, and was the 32nd registered.

Dysphonia

132 studies on the registry are indexed under Dysphonia; 38 are open to participants now.

Browse Dysphonia studies →

Open to participants now

20 of the 71 studies in Dysphonia with a site in United States are open now. Recruiting first, the newest first:

15 more — sign in →

All 20 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 25 Dysphonia studies recruiting now, 8 (32%) set no upper age limit and 9 (36%) stop at 75 or younger; 7 take children under 18; 14 take healthy volunteers.

This study: 65 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 71 studies in Dysphonia with a site in United States, or all of them as a file.
02

Study summary

The objectives for this research are to determine the mechanisms by which specific therapy tasks improve voice in age-related dysphonia, and the conditions that limit the extent of improvement. The central hypothesis is that targeted therapy tasks will improve voice, and that severity will determine the extent of improvement.

03

Conditions studied

  • Presbylarynx
  • Age-Related Dysphonia

Browse trials for

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults in age range who volunteer
  • Can understand and complete directions presented in English
  • People with voice disorder associated with advancing age will be included, including bowing, incomplete closure, mild edema, erythema, signs of laryngopharyngeal reflux.

Exclusion criteria

Exclusion Criteria:

  • Laryngeal differences not related to aging (e.g., vocal fold paralysis, moderate-severe edema, lesions, leukoplakia, dysplasia, Parkinson disease)
  • Known history of stroke, brain injury, or other neurological disorder
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
220 participants (estimated)

Study arms

  • Other
    Participants

    All participants will undergo each treatment.

    Behavioral: Voice therapy: respiratory · Behavioral: Voice therapy: glottal closure · Behavioral: Voice therapy: loud · Behavioral: Voice therapy: Semiocclusion

Interventions

  • BehavioralVoice therapy: respiratory

    Abdominal voice onset

  • BehavioralVoice therapy: glottal closure

    Pulling/pushing task

  • BehavioralVoice therapy: loud

    Assertive task

  • BehavioralVoice therapy: Semiocclusion

    Semi-occluded vocal tract

06

What researchers measure

Primary outcomes

  1. Relative glottal gap from laryngeal high-speed videoendoscopy

    Time frame: End of year 3

  2. Perceived voice quality

    Participants will score the construct of "overall voice quality" using a technique called "sort and rate" in which listeners move icons representing each sound along a line. They align the icons so that best voices are on one side and worst voices are on the other. The distance between the icons represents how much better or worse one sound is than the other. There are no units to the scale. Rankings from all listeners are combined using the statistical technique of multidimensional scaling. The result is a ranked value for each sound file (i.e., voice production) that shows how different they are. There is no highest or lowest value.

    Time frame: End of year 3

  3. Acoustic measure of voice quality (Cepstral Peak Prominence)

    Time frame: End of year 3

Secondary outcomes

  1. Open quotient from laryngeal high-speed videoendoscopy

    Time frame: End of year 3

  2. Speed index from laryngeal high-speed videoendoscopy

    Time frame: End of year 3

  3. Maximum area declination ratefrom laryngeal high-speed videoendoscopy

    Time frame: End of year 3

  4. Fundamental frequency standard deviation from laryngeal high-speed videoendoscopy

    Time frame: End of year 3

07

Study locations

2 sites
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2019 (actual). Primary completion is estimated for Dec 2026, 92 months after the start.

Of 44 non-industry interventional studies with no phase under Dysphonia, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 47. This study's planned 92 months is above that.

Counting every sponsor, half of 44 studies reached it within 26 months; a quarter within 11 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 17, 2018
First posted
Oct 11, 2018
StartActual
Apr 1, 2019
Primary completionEst.
Dec 30, 2026
CompletionEst.
Dec 30, 2026
Last update
Oct 10, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03702322
Collaborators
Mayo Clinic
Responsible party
Sponsor
First posted
Oct 11, 2018
Start date
Apr 1, 2019
Primary completion
Dec 30, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Oct 10, 2025

Study contacts

Robin A Samlan, Ph.D.
principal investigator · University of Arizona

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion